CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 61 filers reported holding CABALETTA BIO INC in Q1 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $756,358 | +669.2% | 49,695 | +552.4% | 0.00% | – |
| Q2 2023 | $98,335 | -74.0% | 7,617 | -83.4% | 0.00% | – |
| Q1 2023 | $378,369 | – | 45,752 | +13356.5% | 0.00% | – |
| Q3 2022 | $0 | – | 340 | -22.2% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 437 | -75.7% | 0.00% | – |
| Q1 2022 | $4,000 | -55.6% | 1,796 | -27.1% | 0.00% | – |
| Q4 2021 | $9,000 | -62.5% | 2,463 | +23.3% | 0.00% | – |
| Q3 2021 | $24,000 | +84.6% | 1,997 | +32.2% | 0.00% | – |
| Q2 2021 | $13,000 | -13.3% | 1,511 | +14.9% | 0.00% | – |
| Q1 2021 | $15,000 | -72.2% | 1,315 | -69.9% | 0.00% | – |
| Q4 2020 | $54,000 | +350.0% | 4,364 | +289.3% | 0.00% | – |
| Q3 2020 | $12,000 | -52.0% | 1,121 | -49.2% | 0.00% | – |
| Q2 2020 | $25,000 | +78.6% | 2,205 | +15.7% | 0.00% | – |
| Q1 2020 | $14,000 | -22.2% | 1,905 | +45.6% | 0.00% | – |
| Q4 2019 | $18,000 | – | 1,308 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 2,064,263 | $4,190,000 | 0.92% |
| Kynam Capital Management, LP | 616,125 | $1,251,000 | 0.41% |
| Ikarian Capital, LLC | 1,020,070 | $2,070,000 | 0.27% |
| Cormorant Asset Management, LP | 1,154,424 | $2,343,000 | 0.18% |
| Ikarian Capital, LLC | 449,000 | $912,000 | 0.12% |
| HARBOR CAPITAL ADVISORS, INC. | 119,315 | $242,000 | 0.11% |
| Boxer Capital, LLC | 540,000 | $1,096,000 | 0.06% |
| SAMLYN CAPITAL, LLC | 1,768,083 | $3,589,000 | 0.05% |
| Redmile Group, LLC | 696,377 | $1,414,000 | 0.04% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 464,252 | $942,000 | 0.02% |